-
1 Comment
Edan Instruments, Inc is currently in a long term downtrend where the price is trading 15.7% below its 200 day moving average.
From a valuation standpoint, the stock is 54.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.4.
Edan Instruments, Inc's total revenue rose by 33.7% to $423M since the same quarter in the previous year.
Its net income has dropped by 9.0% to $17M since the same quarter in the previous year.
Finally, its free cash flow grew by 446936.9% to $216M since the same quarter in the previous year.
Based on the above factors, Edan Instruments, Inc gets an overall score of 3/5.
| ISIN | CNE100001252 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 7B |
|---|---|
| Target Price | None |
| Beta | 0.64 |
| PE Ratio | 34.88 |
| Dividend Yield | 1.7% |
Edan Instruments, Inc. engages in the research, development, manufacture, and service of medical electronic equipment and in vitro diagnostic products in China and internationally. The company offers ECG products, including resting ECG, stress test, holter, wireless solution, and ECG workstation products; patient monitoring systems, such as modular and compact patient monitor, vital signs, and telemetry and IT products; and obstetrics and gynecology products comprising fetal and maternal monitoring systems, fetal telemetry systems, ultrasonic doppler systems, central monitoring systems, video colposcopes, and biofeedback and stimulation systems. It also provides ultrasound systems that include cart-based color doppler, portable color doppler, and B/W ultrasound systems; and in-vitro diagnostics, which comprise hematology analyzers and reagents. In addition, the company offers point-of-care testing systems, including blood gas and chemistry analyzers, molecular diagnostic analysis systems, disposable arterial blood samplers, and blood gas capillary tubes; and veterinary ultrasound, ECG, laboratory, and monitoring products. The company was founded in 1995 and is headquartered in Shenzhen, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300206.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
